Incidence of congenital cytomegalovirus infection in Ireland: Implications for screening and diagnosis

Journal of Clinical Virology

Volumn 59, Issue 3, 2014, Pages 156-160

  Waters, Allison ^a   Jennings, Karen ^b   Fitzpatrick, Emma ^a   Coughlan, Suzie ^a   Molloy, Eleanor J ^b   De Gascun, Cillian F ^c   Hall, William W ^a   Knowles, Susan J ^b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b NATIONAL MATERNITY HOSPITAL   (Ireland)

^c FRIMLEY PARK HOSPITAL   (United Kingdom)

Author keywords

Congenital; Cytomegalovirus; Incidence; Ireland; Newborn screening

Indexed keywords

CONGENITAL; CYTOMEGALOVIRUS; INCIDENCE; IRELAND; NEWBORN SCREENING;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; HUMANS; INCIDENCE; INFANT, NEWBORN; IRELAND; NEONATAL SCREENING; PILOT PROJECTS; SALIVA;

EID: 84893955394     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.12.007     Document Type: Article

References (36)

1. Fowler K.B., Boppana S.B. Congenital cytomegalovirus (CMV) infection and hearing deficit. J Clin Virol 2006, 35(February (2)):226-231.
2. Fowler K.B., Dahle A.J., Boppana S.B., Pass R.F. Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed?. J Pediatr 1999, 135(July (1)):60-64.
3. Pass R.F. Congenital cytomegalovirus infection and hearing loss. Herpes 2005, 12(October (2)):50-55.
4. Ludwig A., Hengel H. Epidemiological impact and disease burden of congenital cytomegalovirus infection in Europe. Euro Surveill 2009, 14(March (9)):26-32.
5. Cannon M.J., Schmid D.S., Hyde T.B. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 2010, 20(July (4)):202-213.
6. Demmler G.J. Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis 1991, 13(March-April (2)):315-329.
7. Kenneson A., Cannon M.J. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007, 17(July-August (4)):253-276.
8. de Vries J.J., Vossen A.C., Kroes A.C., van der Zeijst B.A. Implementing neonatal screening for congenital cytomegalovirus: addressing the deafness of policy makers. Rev Med Virol 2011, 21(January (1)):54-61.
9. Barbi M., Binda S., Caroppo S., Calvario A., Germinario C., Bozzi A., et al. Multicity Italian study of congenital cytomegalovirus infection. Pediatr Infect Dis J 2006, 25(February (2)):156-159.
10. Ross S.A., Fowler K.B., Ashrith G., Stagno S., Britt W.J., Pass R.F., et al. Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity. J Pediatr 2006, 148(March (3)):332-336.
11. Hearing JCoI Year 2000 position statement: principles and guidelines for early hearing detection and intervention programs. Joint Committee on Infant Hearing, American Academy of Audiology, American Academy of Pediatrics, American Speech-Language-Hearing Association, and Directors of Speech and Hearing Programs in State Health and Welfare Agencies. Pediatrics 2000, 106(October (4)):798-817.
12. Griffiths P.D. CMV vaccine trial endpoints. J Clin Virol 2009, 46(December (Suppl. 4)):S64-S67.
13. Boppana S.B., Ross S.A., Shimamura M., Palmer A.L., Ahmed A., Michaels M.G., et al. Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med 2011, 364(June (22)):2111-2118.
14. Boppana S.B., Ross S.A., Novak Z., Shimamura M., Tolan R.W., Palmer A.L., et al. Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA 2010, 303(April (14)):1375-1382.
15. Paradiz K.R., Seme K., Puklavec E., Paro-Panjan D., Poljak M. Prevalence of congenital cytomegalovirus infection in Slovenia: a study on 2841 newborns. J Med Virol 2012, 84(January (1)):109-115.
16. Balcarek K.B., Warren W., Smith R.J., Lyon M.D., Pass R.F. Neonatal screening for congenital cytomegalovirus infection by detection of virus in saliva. J Infect Dis 1993, 167(June (6)):1433-1436.
17. Yamamoto A.Y., Mussi-Pinhata M.M., Marin L.J., Brito R.M., Oliveira P.F., Coelho T.B. Is saliva as reliable as urine for detection of cytomegalovirus DNA for neonatal screening of congenital CMV infection?. J Clin Virol 2006, 36(July (3)):228-230.
18. Bland M. An Introduction to Medical Statistics 2000, Oford Medical Publications. 3rd ed.
19. de Vries J.J., Korver A.M., Verkerk P.H., Rusman L., Claas E.C., Loeber J.G., et al. Congenital cytomegalovirus infection in the Netherlands: birth prevalence and risk factors. J Med Virol 2011, 83(October (10)):1777-1782.
20. Engman M.L., Malm G., Engstrom L., Petersson K., Karltorp E., Tear Fahnehjelm K., et al. Congenital CMV infection: prevalence in newborns and the impact on hearing deficit. Scand J Infect Dis 2008, 40(11-12):935-942.
21. Griffiths P.D., McLean A., Emery V.C. Encouraging prospects for immunisation against primary cytomegalovirus infection. Vaccine 2001, 19(January (11-12)):1356-1362.
22. Paixao P., Almeida S., Gouveia P., Vilarinho L., Vaz Osorio R. Prevalence of human cytomegalovirus congenital infection in Portuguese newborns. Euro Surveill 2009, 14(March (9)):13-15.
23. Dollard S.C., Grosse S.D., Ross D.S. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007, 17(September-October (5)):355-363.
24. Mussi-Pinhata M.M., Yamamoto A.Y., Moura Brito R.M., de Lima Isaac M., de Carvalho e Oliveira P.F., Boppana S., et al. Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population. Clin Infect Dis 2009, 49(August (4)):522-528.
25. Hyde T.B., Schmid D.S., Cannon M.J. Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev Med Virol 2010, 20(September (5)):311-326.
26. Knowles S.J., Grundy K., Cahill I., Cafferkey M.T., Geary M. Low cytomegalovirus sero-prevalence in Irish pregnant women. Ir Med J 2005, 98(July-August (7)):210-212.
27. Adler S.P. Screening for cytomegalovirus during pregnancy. Infect Dis Obstet Gynecol 2011, 2011:1-9.
28. Kimberlin D.W., Acosta E.P., Sanchez P.J., Sood S., Agrawal V., Homans J., et al. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis 2008, 197(March (6)):836-845.
29. Kimberlin D.W., Lin C.Y., Sanchez P.J., Demmler G.J., Dankner W., Shelton M., et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 2003, 143(July (1)):16-25.
30. HSE A Practical Guide to Newborn Bloodspot Screening in Ireland 2011, Health Service Executive. 5th ed. National Newborn Bloodspot Screening Laboratory CsUH (Ed.).
31. Nigro G., Adler S.P., La Torre R., Best A.M. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005, 353(September (13)):1350-1362.
32. Nigro G., Adler S.P., Parruti G., Anceschi M.M., Coclite E., Pezone I., et al. Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy - a case-control study of the outcome in children. J Infect Dis 2012, 205(January (2)):215-227.
33. Hassan J., Herbert M., Smith L., Connell J. Towards improving the retrospective diagnosis of congenital cytomegalovirus infection in dried blood spots. Viral Immunol 2013, 26(August (4)):296-299.
34. Grosse S.D., Dollard S., Ross D.S., Cannon M. Newborn screening for congenital cytomegalovirus: options for hospital-based and public health programs. J Clin Virol 2009, 46(December (Suppl. 4)):S32-S36.
35. Bubbico L., Bartolucci M.A., Broglio D., Boner A. Societal cost of pre-lingual deafness. Ann Ig. 2007, 19(March-April (2)):143-152.
36. Cannon M.J., Davis K.F. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health 2005, 5:70.